A study explores how prior authorization requirements; coverage stoppages and other red tape can generate barriers to life ...

I was diagnosed with follicular lymphoma in 2020, during COVID, which forced me to retire early and taught me I’m more than a ...

Dr. Sara M. Tolaney breaks down key takeaways from the DESTINY-Breast09 trial that patients with HER2+ advanced or metastatic ...

Breyanzi demonstrated a 95.5% response rate among patients with relapsed/refractory marginal zone lymphoma, as well as a ...

Both non-small lung cancer and small cell lung cancer is a disease that now has various therapeutic options available, ...

If there is ever an annual follow up CT scan that does not cause me significant anxiety, this year will be the one.

Dr. Joshua K. Sabari and Jackie Herigodt sat down to discuss the importance of knowing a patient beyond their cancer diagnosis.

I became a colon cancer survivor after my 2020 diagnosis, and I share how my scars, mindset shifts and journaling helped me ...

ASCO Annual Meeting highlighted key advances in brain cancer and brain metastases for patients affected by the disease.

The FDA granted fast track designation to nuvisertib for those with intermediate or high-risk myelofibrosis, which ...

The de-escalation of therapy helps avoid unnecessary toxicity from treatment in patients with brain cancer, explained Drs.

I feel unprepared and overwhelmed after my breast cancer diagnosis, facing treatment like a race, hoping for the strength to ...